NCT04205968
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04205968
Title Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Southwest Oncology Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field